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Abstract
Accurate staging of rectal cancer is essential for selecting patients who can undergo sphincter-
preserving surgery.  It may also identify patients who could benefit from neoadjuvant therapy.
Clinical staging is usually accomplished using a combination of physical examination, CT scanning,
MRI and endoscopic ultrasound (EUS). Transrectal EUS is increasingly being used for locoregional
staging of rectal cancer. The accuracy of EUS for the T staging of rectal carcinoma ranges from 80-
95% compared with CT (65-75%) and MR imaging (75-85%). In comparison to CT, EUS can
potentially upstage patients, making them eligible for neoadjuvant treatment. The accuracy to
determine metastatic nodal involvement by EUS is approximately 70-75% compared with CT (55-
65%) and MR imaging (60-70%). EUS guided FNA may be beneficial in patients who appear to have
early T stage disease and suspicious peri-iliac lymphadenopathy to exclude metastatic disease.
Background
Approximately 41,000 new cases of rectal cancer will be
diagnosed in the year 2006 with an estimated 8,500
deaths [1]. The prognosis and management of this malig-
nancy is dependent upon its stage at the time of initial
presentation. Previously unrecognized lymph node
metastasis may present in up to 10% of T1 lesions and
17% of T2 lesions [2]. In contrast to colon cancer, clinical
preoperative tumor staging is essential since it allows
selection of patients in need of neoadjuvant chemoradia-
tion and those who may benefit from tumor load reduc-
tion to facilitate resection and potentially result in
sphincter-preserving resections. Neoadjuvant chemoradi-
ation is currently recommended for patients with
advanced locoregional rectal cancer, i.e. those with tumor
extension into the perirectal fat and/or involvement of the
mesorectal or pelvic lymph nodes (T3, T4 N0, or Tx N1,
N2) [3]. In these patients, neoadjuvant therapy followed
by surgery results in better local control [4], and similar or
reduced toxicity when compared with standard postoper-
ative adjuvant regimens [5]. The Swedish Rectal Cancer
Trials showed that a short-term regimen of high-dose pre-
operative radiotherapy reduced rates of local recurrence
and improved survival among patients with resectable rec-
tal cancer [6].
Currently available methods for assessment of rectal
tumors include digital rectal examination, rigid proctos-
copy, computer tomography (CT) scan, magnetic reso-
nance imaging (MRI), and endorectal ultrasound (EUS).
Digital examination allows for assessment of size and
degree of fixation of rectal tumors. It has limited value
because of its subjective nature and dependence on the
examiner's experience [7]. Rigid proctoscopy (which is
usually performed in conjunction with rectal digital
examination) provides the most precise assessment of
Published: 18 October 2006
International Seminars in Surgical Oncology 2006, 3:36 doi:10.1186/1477-7800-3-36
Received: 10 October 2006
Accepted: 18 October 2006
This article is available from: http://www.issoonline.com/content/3/1/36
© 2006 Siddiqui et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.International Seminars in Surgical Oncology 2006, 3:36 http://www.issoonline.com/content/3/1/36
Page 2 of 7
(page number not for citation purposes)
tumor location and distance from the anal verge. CT scan
is an excellent modality to evaluate for distant metastasis
and adjacent organ involvement, but lacks specificity for
loco-regional staging due to its inability to distinguish
between mural layers. The staging accuracy for CT scan for
rectal cancer is approximately 75% [8]. The rigid transrec-
tal ultrasound (TRUS) is a diagnostic modality for pre-
operative staging of mid and distal rectal cancers (i.e.
tumors within 10 cm from the anal verge). TRUS makes it
possible for assessment of bowel thickness involvement
and lymph node status. MRI has a similar accuracy to
TRUS and appears to be superior in more advanced
lesions [9-11]. For technical reasons a rigid transrectal US
(TRUS) is less feasible for evaluation for more proximal
rectal cancers.
Transrectal endoscopic ultrasound has emerged as the
diagnostic modality of choice for clinical staging of rectal
tumors. Because EUS can delineate the layers of the rectal
wall [12-14], it is superior to CT in staging accuracy. EUS
and MRI can be used as complementary methods in the
preoperative staging of rectal cancer. EUS is more accurate
in determining bowel wall penetration of the tumor,
while MRI is comparable to EUS in the evaluation of
lymph node involvement [15,16]. In the present report,
we review the current status of EUS in the diagnosis and
staging for rectal cancer.
Technique of rectal EUS
The most widely used EUS endoscopes are available in
two different designs: radial and curved linear array.
Radial echoendoscopes produce a 360° image in a plane
perpendicular to the long axis of the endoscope's inser-
tion tube. Linear devices, on the other hand, produce sec-
tor-shaped images in a plane parallel to the long axis of
the insertion tube. Linear imaging is used for interven-
tional EUS-fine needle aspiration (FNA). EUS sono-
graphic layers of the wall of the GI tract have been
correlated to histopathological layers in several studies
[17]. The standard five layer EUS image of the GI tract wall
and its correlation to histological layers is shown in Figure
1.
Patients who undergo rectal EUS should receive an oral
lavage preparation used typically consisting of polyethyl-
ene glycol electrolyte solution. Tumor staging and lymph
node detection is performed by filling the echoendoscope
ultrasound balloon with water, advancing the scope
above the tumor and slowly withdrawing to the anal
sphincters. The depth of wall invasion, invasion into the
perirectal fat or adjacent organs, and presence of perirectal
lymph nodes are carefully assessed (Figure 2). If a node is
enlarged, EUS may be used to proceed with fine needle
aspiration (FNA) sampling of suspicious lesions (perirec-
tal or iliac lymphadenopathy).
Correlation between the standard five EUS layers and histological layers of the normal intestinal wall Figure 1
Correlation between the standard five EUS layers and histological layers of the normal intestinal wall. 1st = interface between 
fluid in the lumen and the superficial mucosa; 2nd = lamina propria and muscularis mucosa, or deep mucosa; 3rd = submucosa 
and interface between submucosa and muscularis propria; 4th = muscularis propria; circular (4a) and longitudinal (4c) are not 
usually seen as separate layers; 5th = interface between serosa and surrounding adventitial tissue.International Seminars in Surgical Oncology 2006, 3:36 http://www.issoonline.com/content/3/1/36
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Staging of rectal cancer
Prognosis of rectal cancer depends on its local, nodal, and
distant tumor status. Rectal cancer is staged using the
Tumor-Node-Metastasis (TNM) staging system, which is
similar to colon cancer (Table 1). Rectal cancer has the
appearance of a hypoechoic lesion which disrupts the nor-
mal five-layer structure of the rectal wall. The accuracy of
EUS for the T staging of rectal carcinoma ranges from 80–
95% [13,18] compared with CT (65–75%) and MR imag-
ing (75–85%) [13,18-20].
One of the limitations of EUS is the under-staging of T3
tumors, which is caused by the inability to detect micro-
scopic cancer infiltration owing to the limits its resolu-
tion. Other factors influencing the accuracy of tumor
staging are operator experience [8,21,22] and the level of
the tumor, with reduced accuracy for tumors lower in the
rectum [8,23]. Staging accuracy is best for T2 tumors (Fig-
ure 3) [24]. However, over-staging of T2 tumors may
occur as a result of inflammation around the tumor which
is sonographically indistinguishable from malignant tis-
sue [25]. Circumferential rectal tumors causing stenosis
may not be able to be staged accurately because of inabil-
ity to traverse the stenosis by the endoscope [26]. Addi-
tionally, preoperative radiotherapy decreases the EUS
accuracy for T stage interpretation because of the
increased echogenicity of the rectal wall resulting from
radiation therapy [27].
The accuracy to determine metastatic nodal involvement
by EUS is approximately 70–75% [18,19,28] compared
with CT (55–65%) [20,29] and MR imaging (60–70%)
[19,30]. Nodal staging by EUS is less accurate than tumor
staging due to difficulty of detecting tumor within a
lymph node. Lymph node changes associated with malig-
nant involvement by EUS include a hypoechoic appear-
ance, round shape of the node, and nodal diameter of 1
cm or greater (Figure 4) [25,27,31]. A rectal cancer with a
malignant perirectal lymph node (L) is demonstrated in
Figure 4. Lymph nodes greater than 0.5 cm in diameter
have a 50–70% possibility of being metastatic, whereas
those smaller than 4 mm have a less than 20% likelihood
[7].
EUS-guided FNA does not improve the preoperative stag-
ing of rectal cancer in most patients. Harewood et al eval-
uated the role of EUS-guided FNA of perirectal lymph
nodes in the preoperative assessment of a cohort of 80
patients with newly diagnosed, nonmetastatic rectal can-
cer [32]. The overall accuracy for N staging was similar
(80%) for CT, EUS, and EUS FNA with no benefit in accu-
racy from performing FNA. FNA may not significantly
improve nodal involvement accuracy compared to EUS
alone because perirectal lymph nodes are usually too
small to be visualized by EUS unless they contain meta-
static disease.
The overall accuracy of EUS, CT scan and MRI in the stag-
ing rectal cancer compared with surgical pathology is
summarized in table 2.
The impact of rectal EUS on management
The routine utilization of EUS for assessment and deter-
mination of tumor penetration into the bowel wall is
essential for rectal cancer. This has become the standard of
care as it allows for identification of patients in whom to
administer preoperative neoadjuvant therapy [32]. Analy-
sis of a cohort of 80 patients with diagnosed rectal cancer
showed that EUS was more accurate than CT for determin-
ing T stage of rectal carcinoma. The addition of rectal EUS
to the diagnostic work-up resulted in a change in the
number of patients receiving preoperative adjuvant ther-
apy in nearly one third of these patient, which reflects the
accuracy of EUS compared to CT scan or MRI. On the
other hand, it is possible that the aggressive use of EUS
may lead to over staging and over treating of rectal tumors
which would typically only need resection. However, the
positive predictive value (PPV) for identifying T3/T4 dis-
ease by EUS was 100%. Additionally, rectal EUS can detect
patients with advanced T stage disease missed by CT who
will benefit from preoperative treatment. Thus, the risk
benefit ratio of over staging is justified. Even with aggres-
sive EUS practices, EUS understaged 15% of those patients
in whom neoadjuvant therapy would typically be consid-
ered. Yet, this was lower than CT scan, which understage
tumors in 39% of patients [32]. Additionally, cost-effec-
tiveness analysis of 3 different staging strategies (abdomi-
nal and pelvic CT versus abdominal CT plus EUS versus
abdominal CT plus pelvic MRI) found that abdominal CT
plus EUS is the most cost-effective approach for nonmet-
astatic proximal rectal cancer [33]. The correlation of stag-
ing by EUS with the treatment protocol for rectal cancer is
summarized in Table 3.
Rectal EUS staging after radiation therapy
Accuracy of EUS for staging rectal cancer after radiation
therapy is decreased markedly due to post-radiation
edema, inflammation, necrosis, and fibrosis. Studies sug-
gest that the T-stage accuracy after radiation is 50%, with
a 40% overstaging rate [27,34]. Lymph node staging accu-
racy is also decreased. Thus, at this juncture, restaging
tumors after neoadjuvant therapy is limited and clinical
correlation is most important to dictate operative and
postoperative management modalities.
Recurrent rectal cancer
Local recurrence rate after surgery alone for advanced rec-
tal cancer is approximately 25% and decreases to 10%
after radiation [33]. The risk of recurrence is greatest in theInternational Seminars in Surgical Oncology 2006, 3:36 http://www.issoonline.com/content/3/1/36
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Table 1: AJCC TNM Rectal Cancer Staging
TX Primary tumor can not be assessed.
T0 No primary tumor identified.
Tis Carcinoma in situ (tumor limited to mucosa).
T1 Involvement of submucosa, but no penetration through muscularis 
propria.
T2 Invasion into, but not penetration through, muscularis propria.
T3 Penetration through muscularis propria into subserosa (if present), or 
pericolic fat, but not into peritoneal cavity or other organs.
T4 Invasion of other organs or involvement of free peritoneal cavity.
NX Nodal metastasis can not be assessed.
N0 No nodal metastasis.
N1 1–3 pericolic/perirectal nodes involved.
N2 4 or more pericolic/perirectal nodes involved.
MX Distant metastasis can not be assessed.
M0 No distant metastases.
M1 Distant metastases
EUS image of T1 rectal cancer confined to mucosa and superficial submucosa Figure 2
EUS image of T1 rectal cancer confined to mucosa and superficial submucosa.
SM=submucosa, MP=muscularis propria,  SR=serosa.
MP
SR
EUS Probe
Rectal 
Tumor
SM
Seminal vesicles
Table 2: Accuracy of rectal US in staging rectal cancer compared with surgical pathology
T-Staging N-Staging
EUS 80–95% [13;18] 70–75% [18;19;28]
Helical CT 65–75% [13;18-20] 55–65% [20;29]
MRI 75–85% [13;18-20] 60–70% [19;30]International Seminars in Surgical Oncology 2006, 3:36 http://www.issoonline.com/content/3/1/36
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first 2 years after surgery. Early detection of recurrent local
tumor might result in earlier treatment and improved sur-
vival. The ability of CT scan is limited because if may not
be able to distinguishing recurrence from postoperative
change due to fibrosis or inflammation [35]. CT images
can also be obscured by artifacts from surgically placed
metal clips. Two prospective studies demonstrated that
EUS was superior to CT scan for local recurrence detection
in rectal cancer [35,36]. The sensitivity of EUS for detect-
ing recurrence was higher (100 percent) in both studies
compared to CT (82 to 85 percent). EUS was also more
sensitive than digital rectal examination, CT and CEA lev-
els to detect local recurrence of rectal cancer in patient
who were asymptomatic from their disease [37]. EUS spe-
cificity is limited by its inability to distinguish between
mucosal inflammation and recurrence. Although the opti-
mal interval for repeating EUS after surgical treatment of
rectal cancer is unknown, performing rectal EUS every 6
months for the first 2 years after low anterior resection or
transanal excision may be a reasonable screening for
recurrent rectal cancer [38, 39].
Conclusion
The use of preoperative EUS is an accurate modality for
clinical staging of rectal cancer to guide neoadjuvant treat-
ment. EUS guided-FNA may be beneficial in patients who
appear to have early T stage disease and suspicious peri-
iliac lymphadenopathy. Whether the accurate staging
ability of EUS and EUS guided-FNA translates into
improved outcomes in terms of reduced recurrence rates
and ultimately prolonged survival remains uncertain. At
this juncture, the utility of FNA-guided needle aspiration
for evaluation of metastatic disease remains unclear.
Table 3: Correlation of staging with recommended treatment for rectal cancer
EUS STAGE HISTOPATHOLOGICAL STAGING THERAPY
UT1 Invasion of mucosa and submucosa Excision
UT2 Invasion of tumor into the muscularis propia Excision
UT3 Invasion of tumor through the serosa Pre-op chemoradiotherapy → resection of 
tumor
UT4 Invasion of tumor into adjacent organs Pre-op chemoradiotherapy → resection of 
tumor → post-op chemotherapy
EUS image of T2 rectal cancer invading the muscularis propria Figure 3
EUS image of T2 rectal cancer invading the muscularis propria.
MP invasion
TUMOR
EUS PROBEInternational Seminars in Surgical Oncology 2006, 3:36 http://www.issoonline.com/content/3/1/36
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